Interferon beta-1a
Cytokine in the interferon family / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Interferon beta-1a?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS).[5] It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli.[6] Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses.[7]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Avonex, Rebif, Plegridy, others |
AHFS/Drugs.com | Professional Drug Facts |
MedlinePlus | a604005 |
License data |
|
Pregnancy category |
|
Routes of administration | Subcutaneous, intramuscular |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Elimination half-life | 10 hrs |
Identifiers | |
| |
CAS Number | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C908H1408N246O252S7 |
Molar mass | 20027.14 g·mol−1 |
NY (what is this?) (verify) |
Close
Interferon beta has not been shown to slow the advance of disability.[8][9][10][11] Interferons are not a cure for MS (there is no known cure); the claim is that interferons may slow the progress of the disease if started early and continued for the duration of the disease.[12]